Helix BioPharma Corp. logo

Helix BioPharma Corp. (HBP)

Market Closed
16 Jun, 20:00
TSX TSX
CA$
1. 50
+0.01
+0.6711%
CA$
41.18M Market Cap
- P/E Ratio
- Div Yield
1,093 Volume
0 Eps
CA$ 1.49
Previous Close
Add Transaction
Day Range
1.4 1.52
Year Range
0.84 5.4
Want to track HBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Helix BioPharma Corp. (HBP) Statistics

Valuation metrics

Market Cap 41.18M
Enterprise value 121.01M
Trailing P/E (ttm) -28.76
Forward P/E -
PEG ratio -0.5
Price/Sales (ttm) -
Price/Book (mrq) 7.86
Enterprise Value/Revenue -
Enterprise Value/EBITDA -30.75

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 449
Average volume (90 days) 2.34K

Price summary

52-Week low 0.84
52-Week high 5.4
Beta -
50-Day moving average 1.71
200-Day moving average 1.96

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 16 Aug 2024

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -0.23%
Return on equity -0.37%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.05
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 0.04%
Book value per share (mrq) 0.2

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -